Q97781471

Summary

Q97781471 is an individual motion^[1].

Key Facts

• Q97781471 authored Fredrik Olovsson^[2].
• Q97781471's instance of is recorded as individual motion^[3].
• Q97781471's part of the series is recorded as motions of 2012-2013 legislative session of the Riksdag^[4].
• Q97781471's language of work or name is recorded as Swedish^[5].
• Q97781471 was published on +2012-10-01T00:00:00Z^[6].
• Q97781471's main subject is medication^[7].
• Q97781471's work available at URL is recorded as http://data.riksdagen.se/dokument/H002So299^[8].
• Q97781471's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/H002So299^[9].
• Q97781471's applies to jurisdiction is recorded as Sweden^[10].
• Q97781471's legal citation of this text is recorded as Mot. 2012/13:So299^[11].
• Q97781471's title is recorded as Marknadsföring av receptfria läkemedel^[12].
• Q97781471's copyright status is recorded as public domain^[13].
• Q97781471's legislative committee is recorded as Committee on Health and Welfare^[14].

Body

Definition and Type

Q97781471's instance of is recorded as individual motion^[3].